SOD1 and type 2 diabetes mellitus: In the HepG2 cell line, which mimics the lipid disorders seen in T2DM, the pretreatment with BSE significantly increased CAT, SOD, and GPx, decreased the MDA content, and exhibited an inhibitory activity on α-amylase.